首页> 美国卫生研究院文献>PLoS Clinical Trials >Coagulant activity of recombinant human factor VII produced by lentiviral human F7 gene transfer in immortalized hepatocyte-like cell line
【2h】

Coagulant activity of recombinant human factor VII produced by lentiviral human F7 gene transfer in immortalized hepatocyte-like cell line

机译:慢病毒人F7基因转移产生的重组人因子VII在永生化肝细胞样细胞系中的凝结活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human mesenchymal stem cells (hMSCs) have the potential to differentiate into hepatocyte-like cells, indicating that these cells may be the new target cell of interest to produce biopharmaceuticals. Our group recently established a hMSC-derived immortalized hepatocyte-like cell line (imHC) that demonstrates several liver-specific phenotypes. However, the ability of imHC to produce coagulation factors has not been characterized. Here, we examined the potential for imHC as a source of coagulation protein production by investigating the ability of imHC to produce human factor VII (FVII) using a lentiviral transduction system. Our results showed that imHC secreted a low amount of FVII (~22 ng/mL) into culture supernatant. Moreover, FVII from the transduced imHC (0.11 ± 0.005 IU/mL) demonstrated a similar coagulant activity compared with FVII from transduced HEK293T cells (0.12 ± 0.004 IU/mL) as determined by chromogenic assay. We demonstrate for the first time, to the best of our knowledge, that imHC produced FVII, albeit at a low level, indicating the unique characteristic of hepatocytes. Our study suggests the possibility of using imHC for the production of coagulation proteins.
机译:人间充质干细胞(hMSCs)具有分化成肝细胞样细胞的潜力,表明这些细胞可能是生产生物药物的新目标靶细胞。我们的小组最近建立了hMSC衍生的永生化肝细胞样细胞系(imHC),该细胞系表现出几种肝特异性表型。但是,imHC产生凝血因子的能力尚未得到表征。在这里,我们通过研究慢病毒转导系统研究imHC产生人因子VII(FVII)的能力,检查了imHC作为凝血蛋白生产来源的潜力。我们的结果表明,imHC在培养上清液中分泌了少量的FVII(〜22 ng / mL)。此外,通过显色分析确定,与来自转导的HEK293T细胞的FVII(0.12±0.004 IU / mL)相比,来自转导的imHC(0.11±0.005 IU / mL)的FVII显示出相似的凝血活性。据我们所知,我们首次证明了imHC产生的FVII尽管水平很低,但它表明了肝细胞的独特特征。我们的研究表明使用imHC产生凝血蛋白的可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号